Loading page…
Laboratorios Farmaceuticos Rovi SA 2022 Integrated Report
Company: Laboratorios Farmaceuticos Rovi SA
Sector: Manufacturing
Country: Spain
Year: 2022
Type: Integrated Report
Pages: 205
The report presents ROVI's strong 2022 growth, including total revenue of 819.8 million euros and a 14% workforce increase to 1,993 employees. It describes the Group's first double-materiality approach, an ESG Master Plan approved by the Board, and expanded climate-risk analysis following TCFD recommendations. Environmental disclosures include 6,693 tonnes of Scope 1 emissions, 616 tonnes of Scope 2 emissions, and 10,352 tonnes of Scope 3 emissions, alongside Scope 1 and 2 carbon neutrality for the third consecutive year.
Indicators available in this report: